Table 1.

Clinical characteristics of none, mild, and moderate PSD groups of RA subjects who do not satisfy modified ACR research criteria for FM. Groups differ for all symptoms at p < 0.5 using Scheffe multiple comparison test. Values are mean (SD) or % unless otherwise specified.

VariablesPSD, 0–3PSD, 4–7PSD, 8–11
PSD categoryNoneMildModerate
Subjects, n717777511
Patients26.228.418.7
Age, yrs66.7 (11.7)66.0 (12.4)65.4 (11.8)
Male23.419.019.0
Pain, 0–101.3 (1.4)2.7 (2.1)4 (2.4)
Global severity, 0–101.4 (1.5)2.8 (1.9)3.9 (2.1)
HAQ, 0–30.4 (0.5)0.8 (0.6)1.1 (0.6)
SF-36, PCS47.4 (9)40.2 (9.8)34.6 (9.2)
SF-36, MCS57.5 (6.4)53.4 (8.8)49.6 (10.6)
GAD anxiety score0.2 (0.6)0.4 (0.9)0.8 (1.2)
GAD probable anxiety disorder1.33.46.8
PHQ-2 depression score0.1 (0.4)0.4 (0.8)0.7 (1.1)
PHQ-2 probable depression disorder0.12.35.6
PHQ-4 score0.3 (0.8)0.8 (1.5)1.5 (2.1)
SSS-8 score2.8 (2.4)6.1 (3.3)9.3 (3.9)
SSS-8 categories
  None to minimal, 0–368.322.74.9
  Low, 4–726.646.731.1
  Medium, 8–114.723.835
  High, 12–150.46.222.1
  Very high, 16–320.00.76.8
WPI, 0–190.8 (0.9)2.6 (1.4)5 (1.9)
SSS, 0–120.9 (1)2.8 (1.4)4.3 (1.8)
FM research survey criteria0.00.00.0
PSD, 0–311.7 (1.1)5.4 (1.1)9.3 (1.1)
Widespread pain0.818.057.5
  • PSD: polysymptomatic distress scale; RA: rheumatoid arthritis; ACR: American College of Rheumatology; FM: fibromyalgia; HAQ: Health Assessment Questionnaire-Disability Index; SF-36: Medical Outcomes Study Short Form-36; PCS: physical component summary score; MCS: mental component summary score; GAD: generalized anxiety disorder; PHQ-2: patient health questionnaire-2; PHQ-4: patient health questionnaire-4; SSS-8: somatic symptom score; WPI: widespread pain index; SSS: symptom severity scale.